Bibliography
- Begum T, Chowdhury SR. Aetiology and pathogenesis of endometriosis - a review. Mymensingh Med J 2013;22:218-21
- Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update 2009;15:441-61
- Streuli I, de Ziegler D, Santulli P, et al. An update on the pharmacological management of endometriosis. Expert Opin Pharmacother 2013;14:291-305
- Soares SR, Martínez-Varea A, Hidalgo-Mora JJ, et al. Pharmacologic therapies in endometriosis: a systematic review. Fertil Steril 2012;98:529-55
- Beyer DA, Amari F, Thill M, et al. Emerging gonadotropin-releasing hormone agonists. Expert Opin Emerg Drugs 2011;16:323-40
- Brown J, Pan A, Hart RJ. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev 2010;12:CD008475
- Olive DL. Optimizing gonadotropin-releasing hormone agonist therapy in women with endometriosis. Treat Endocrinol 2004;3:83-9
- Magon N. Gonadotropin releasing hormone agonists: expanding vistas. Indian J Endocrinol Metab 2011;15:261-7
- Brown J, Kives S, Akhtar M. Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev 2012;3:CD002122
- Gestrinone Italian Study Group. Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double-blind study. Fertil Steril 1996;66:911-19 [Gestrinone versus leuprolide acetate]
- Regidor PA, Regidor M, Schmidt M, et al. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis. Gynecol Endocrinol 2001;15:202-9[ Lynestrenol versus leuprolide acetate]
- Strowitzki T, Marr J, Gerlinger C, et al. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod 2010;25:633-41[ Dienogest versus leuprolide acetate]
- Guzick DS, Huang LS, Broadman BA, et al. Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain. Fertil Steril 2011;95:1568-73[ norethindrone plus estradiol versus leuprolide acetate]
- Rock JA. The revised American Fertility Society classification of endometriosis: reproducibility of scoring. ZOLADEX Endometriosis Study Group. Fertil Steril 1995;63:1108-10
- Biberoglu KO, Behrman SJ. Dosage aspects of danazol therapy in endometriosis: short-term and long-term effectiveness. Am J Obstet Gynecol 1981;139:645-54
- Jensen MP, Turner JA, Romano JM, et al. Visual Analog Score: comparative reliability and validity of chronic pain intensity measures. Pain 1999;83:157-62
- Beck AT, Steer RA, Brown GK. Beck depression inventory manual. 2nd edition. Psychological Co., San Antonio; 1996
- Surrey ES. Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show? Curr Opin Obstet Gynecol 2010;22:283-8
- McCormack PL. Dienogest: a review of its use in the treatment of endometriosis. Drugs 2010;70:2073-88
- Klipping C, Duijkers I, Remmers A, et al. Ovulation-inhibiting effects of dienogest in a randomized, dose-controlled pharmacodynamic trial of healthy women. J Clin Pharmacol 2012;52:1704-13
- Strowitzki T, Faustmann T, Gerlinger C, et al. Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol 2010;151:193-8
- Schroder AK, Diedrich K, Ludwig M. Medical management of endometriosis: a systematic review. IDrugs 2004;7:451-63
- Vercellini P, DE Matteis S, Somigliana E, et al. Long-term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2013;92:8-16